Diagnosis and Natural History Study of Patients With Neurological Conditions

This study has been completed.

First Received on November 3, 1999. Last Updated on March 3, 2008 History of Changes

Sponsor:	National Institute of Neurological Disorders and Stroke (NINDS)
Information provided by:	National Institutes of Health Clinical Center (CC)
ClinicalTrials.gov Identifier:	NCT00001549

Purpose

The purpose of this study is to improve understanding of neurological conditions. Patients participating in this study will continue receiving medical care, routine laboratory tests, and diagnostics tests (X-rays, CT-scans, and nuclear imaging), from their primary care physician. Doctors at the NIH plan to follow these patients and offer advice and assistance to their primary care physicians.

Condition
Alzheimer's Disease Dementia Movement Disorder Multiple System Atrophy Parkinson's Disease

Study Type:	Observational
Official Title:	Diagnosis and Natural History Protocol for Patients With Neurological Conditions

Resource links provided by NLM:

Genetics Home Reference related topics: Alzheimer disease familial paroxysmal nonkinesigenic dyskinesia multiple system atrophy Parkinson disease Perry syndrome progressive supranuclear palsy

MedlinePlus related topics: Alzheimer's Disease Dementia Movement Disorders Neurologic Diseases Parkinson's Disease

U.S. FDA Resources

Further study details as provided by National Institutes of Health Clinical Center (CC):

Estimated Enrollment:	600
Study Start Date:	October 1995
Estimated Study Completion Date:	January 2006

Detailed Description:

The objective of this protocol is to provide diagnosis and follow Experimental Therapeutics Branch (ETB) patients not currently entered on another research protocol. No investigational treatments will be administered on this protocol, and the NIH physicians will be playing largely a consultative role to the patient's primary physician.

Eligibility

Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

INCLUSION CRITERIA:

Patients may be included on this protocol if they have an identifiable neurological disorder or represent a diagnostic puzzle. These disorders would include patients with Parkinson's disease, Alzheimer's disease, multiple system atrophy, progressive supranuclear palsy, restless legs syndrome, other cognitive and movement disorders, and diagnostic puzzles.

Patients 18-90 years of age, inclusive, are eligible.

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00001549

Locations

United States, Maryland
National Institute of Neurological Disorders and Stroke (NINDS)
Bethesda, Maryland, United States, 20892

Sponsors and Collaborators

National Institute of Neurological Disorders and Stroke (NINDS)

More Information

No publications provided

ClinicalTrials.gov Identifier:	NCT00001549 History of Changes
Other Study ID Numbers:	960009, 96-N-0009
Study First Received:	November 3, 1999
Last Updated:	March 3, 2008
Health Authority:	United States: Federal Government

Keywords provided by National Institutes of Health Clinical Center (CC):

Movement Disorders
Parkinson's
Alzheimer's
Screening
Diagnostic Puzzles
Alzheimer Disease

Progressive Supranuclear Palsy
PSP
Restless Leg Syndrome
RLS
Parkinsonism
PD

Additional relevant MeSH terms:

Alzheimer Disease
Dementia
Movement Disorders
Parkinson Disease
Multiple System Atrophy
Shy-Drager Syndrome
Atrophy
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Tauopathies

Neurodegenerative Diseases
Delirium, Dementia, Amnestic, Cognitive Disorders
Mental Disorders
Parkinsonian Disorders
Basal Ganglia Diseases
Primary Dysautonomias
Autonomic Nervous System Diseases
Hypotension
Vascular Diseases
Cardiovascular Diseases
Pathological Conditions, Anatomical

ClinicalTrials.gov processed this record on February 12, 2012